Valuation: NIOX Group Plc

Market Cap 286M 381M 342M 316M 535M 36.28B 541M 3.78B 1.5B 18.99B 1.43B 1.4B 60.27B P/E 2026 *
37x
P/E 2027 * 25.6x
Enterprise Value 259M 344M 309M 286M 483M 32.8B 489M 3.42B 1.36B 17.16B 1.29B 1.27B 54.49B EV / Sales 2026 *
5.14x
EV / Sales 2027 * 4.65x
Free-Float
78.25%
Yield 2026 *
2.71%
Yield 2027 * 3.07%
1 day-1.45%
1 week+3.03%
Current month-1.45%
1 month+3.66%
3 months+11.48%
6 months+0.59%
Current year+2.41%
1 week 66
Extreme 66
70
1 month 65.4
Extreme 65.4
80
Current year 53.84
Extreme 53.84
80
1 year 53.84
Extreme 53.84
80
3 years 53.4
Extreme 53.4
80
5 years 29
Extreme 29
80
10 years 12.5
Extreme 12.5
115.61
Manager TitleAgeSince
Chief Executive Officer - 16/01/2025
Director of Finance/CFO - 14/05/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 58 08/02/2018
Director/Board Member - 02/09/2019
Chairman 73 05/12/2019
Date Insider Type Main position Quantity % Market Cap. Importance
29/5/26 Buy

Chief Financial Officer

34,127 0.0081%
29/5/26 Sell

Chief Financial Officer

-33,916 0.0081%
28/5/26 Sell

Chief Financial Officer

-34,219 0.0081%
Change 5-day change 1-year change 3-year change Capi.($)
-1.45%+3.03%-3.41%+8.97% 381M
+0.50%+1.38%+57.09%+129.96% 1,148B
+0.86%+5.14%+45.00%+86.15% 652B
-0.14%+0.42%+25.69%+105.85% 505B
-0.05%+1.73%+52.74%+67.74% 384B
-0.63%-5.97%+61.93%+37.06% 348B
+0.34%+1.84%+30.70%+54.27% 294B
-0.45%+1.19%+2.89%+26.08% 264B
+0.87%+3.08%+54.69%+72.74% 244B
+0.08%+3.67%+35.05%+107.78% 197B
Average -0.01%+1.61%+36.24%+69.66% 403.75B
Weighted average by Cap. +0.26%+1.56%+44.52%+89.09%

Financials

2026 *2027 *
Net sales 50.36M 67.04M 60.15M 55.61M 94.09M 6.38B 95.23M 665M 265M 3.34B 252M 246M 10.61B 54.23M 72.19M 64.76M 59.88M 101M 6.87B 103M 716M 285M 3.6B 271M 265M 11.42B
Net income 8.5M 11.31M 10.15M 9.39M 15.88M 1.08B 16.07M 112M 44.7M 564M 42.46M 41.56M 1.79B 11.23M 14.95M 13.42M 12.4M 20.99M 1.42B 21.24M 148M 59.07M 745M 56.11M 54.93M 2.37B
Net Debt -27.45M -36.55M -32.79M -30.31M -51.29M -3.48B -51.91M -362M -144M -1.82B -137M -134M -5.78B -34.23M -45.56M -40.88M -37.79M -63.95M -4.34B -64.72M -452M -180M -2.27B -171M -167M -7.21B
Projected Income Statement - Annual - NIOX Group Plc
Logo NIOX Group Plc
NIOX Group plc is a United Kingdom-based diagnostics and management company. The Company is engaged in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNO), a precise biomarker for asthma. The Company's NIOX VERO is also the device of choice by clinical research organizations for respiratory studies. The device is used by healthcare professionals to improve asthma care, which assists diagnosis, determining responsiveness to inhaled corticosteroids, tailoring inhaled steroid use, monitoring treatment compliance, and reducing the likelihood of exacerbations in at-risk patients compared to traditional monitoring. The Company provides products and services via its direct sales organization and extensive distributor network in over 50 countries.
Employees
97
Date Price Change Volume
28/10/26 GBX 68.00 -1.45% 890,957
27/10/26 GBX 69.00 +2.99% 253,075
26/10/26 GBX 67.00 -2.62% 235,850
23/10/26 GBX 68.80 +1.47% 104,057
22/10/26 GBX 67.80 +2.73% 15,793,009
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - NIOX Group Plc
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
0.6800GBP
Average target price
0.8240GBP
Spread / Average Target
+21.18%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - NIOX Group Plc